Frailty, Hip Fractures and Inflammatory Biomarkers
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Frailty, Hip Fracture, Inflammatory Biomarkers. Basic parameters: from 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Greece
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Frailty in Hip Fracture Patients Treated With Surgery; the Role of Simple Inflammatory Biomarkers. An Observational Study
Overview
We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Detailed description
Frailty (F) is a prevalent syndrome among elderly patient with hip fractures (HF) and has been linked to poor prognosis. Inflammatory biomarkers have been used as prognostic indexes in patients with HF. We ought to investigate if hip fracture patients suffering from frailty have higher inflammatory burden according to simple inflammatory biomarkers.
Primary outcome measures
- Frailty status [Time frame: preoperatively]
- Inflammatory biomarkers [Time frame: preoperatively]
Eligibility criteria
Inclusion criteria
- age \>65 years, ASA PS I-III, non- institutionalized, able to communicate patients
Exclusion criteria
- Patients with severe cognitive dysfunction, those treated conservatively, those with pathological fractures and patients who refused to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Greece · 2 centers
- Larissa University Hospital — Larissa
- UHL — Larissa
Identifiers
NCT: NCT06614478 · Frailty and hip fractures